Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:charity
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:DMT
|
| gptkbp:affects |
anxiety
euphoria hallucinations altered perception intense visual experiences |
| gptkbp:composed_of |
from indole
from tryptophan |
| gptkbp:cultural_significance |
used in shamanic rituals
subject of documentaries featured in books part of indigenous traditions explored in modern spirituality |
| gptkbp:discovered_by |
discovered in 1931
|
| gptkbp:dissolved |
soluble in water
soluble in ethanol soluble in chloroform |
| gptkbp:duration |
short duration
typically 15-60 minutes |
| gptkbp:field_of_study |
gptkb:psychologist
pharmacology neuroscience psychedelic studies |
| https://www.w3.org/2000/01/rdf-schema#label |
N, N-Dimethyltryptamine
|
| gptkbp:ingredients |
C12 H16 N2
|
| gptkbp:is_found_in |
gptkb:Mimosa_hostilis
gptkb:Ayahuasca gptkb:Psychotria_viridis various plants |
| gptkbp:legal_issue |
controlled substance in many countries
|
| gptkbp:manager |
smoking
intravenous injection oral consumption |
| gptkbp:mass |
188.25 g/mol
|
| gptkbp:melting_point |
-1 ° C (30 mm Hg)
|
| gptkbp:metabolism |
rapidly metabolized by MAO
|
| gptkbp:previous_name |
N, N-dimethyl-1 H-indole-3-ethanamine
|
| gptkbp:products |
gptkb:5-Me_O-DMT
gptkb:bufotenin serotonin |
| gptkbp:type_of |
61-54-1
|
| gptkbp:uses |
gptkb:spiritual_practices
therapeutic applications psychedelic research |